Anavex Life Sciences Corp. (LON:0HFR)
London
· Delayed Price · Currency is GBP · Price in USD 8.04
+0.22 (2.84%)
At close: Jun 6, 2025
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of 521.98 million as of June 6, 2025. Its market cap has increased by 80.27% in one year.
Market Cap
521.98M
Enterprise Value
436.39M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
8.04
Market Cap Chart
Since April 13, 2006, Anavex Life Sciences's market cap has increased from 182.56K to 521.98M, an increase of 285,824.71%. That is a compound annual growth rate of 51.49%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 165.92B |
| GSK plc | 61.28B |
| Haleon | 36.29B |
| Smith & Nephew | 9.77B |
| ConvaTec Group | 6.03B |
| Hikma Pharmaceuticals | 4.64B |
| HUTCHMED (China) | 1.91B |
| Genus | 1.30B |